Cargando…

The High Diagnostic Accuracy of Combined Test of Thyroid Transcription Factor 1 and Napsin A to Distinguish between Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta-Analysis

BACKGROUND: Accurate classification of non-small cell lung cancer (NSCLC) using morphological features has several limitations. However, the use of thyroid transcription factor 1 (TTF-1) and Napsin A as markers for the identification of various subtypes of NSCLC has shown promise. This meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Li, Li, Xiaorong, Yin, Jieyun, Song, Xia, Chen, Xiaochen, Feng, Jiane, Gao, Hongyu, Liu, Li, Wei, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086931/ https://www.ncbi.nlm.nih.gov/pubmed/25003505 http://dx.doi.org/10.1371/journal.pone.0100837

Ejemplares similares

Significance of thyroid transcription factor 1 and Napsin A for prompting the status of EGFR mutations in lung adenocarcinoma patients
por: Ren, Xiaolu, et al.
Publicado: (2022)

Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma
por: Mohammed Salama, Maha Elsayed
Publicado: (2020)

Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma
por: Uchida, Akifumi, et al.
Publicado: (2017)

Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma
por: Ueno, T, et al.
Publicado: (2003)

Immunoexpression of napsin a in renal neoplasms
por: Zhu, Bing, et al.
Publicado: (2015)

Napsin A and Thyroid Transcription Factor-1-Positive Cerebellar Tumor with Epidermal Growth Factor Receptor Mutation
por: Kuwata, Taiji, et al.
Publicado: (2011)

Napsin A Expression in Human Tumors and Normal Tissues
por: Weidemann, Sören, et al.
Publicado: (2021)

Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: Napsin A expression and genomic alterations
por: Rekhtman, Natasha, et al.
Publicado: (2017)

Napsin A as a marker of clear cell ovarian carcinoma
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2013)

Diagnostic accuracy of S-Detect in distinguishing benign and malignant thyroid nodules: A meta-analysis
por: Zhong, Lin, et al.
Publicado: (2022)

Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A
por: Dong, Yunlong, et al.
Publicado: (2020)

Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma
por: Bulutay, Pınar, et al.
Publicado: (2021)

A case of napsin A-positive metastatic lung cancer originating from the colon
por: Ito, Tomokazu, et al.
Publicado: (2017)

A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma
por: Li, Hui, et al.
Publicado: (2017)

Trefoil Factor 3 as a Novel Biomarker to Distinguish Between Adenocarcinoma and Squamous Cell Carcinoma
por: Wang, Xiao-Nan, et al.
Publicado: (2015)

Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma
por: Xiao, Jian, et al.
Publicado: (2017)

Prevalence of Thyroid Transcription Factor-1 (TTF-1)-Negative Small Cell Carcinoma and Napsin A Positivity in Small Cell Carcinoma in a Cross-Sectional Study of Lung Core Biopsies
por: Sayeda, Shahistha, et al.
Publicado: (2023)

The diagnostic accuracy of superb microvascular imaging in distinguishing thyroid nodules: A protocol for systematic review and meta analysis
por: Tian, Congliang, et al.
Publicado: (2020)

Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases
por: Gurda, Grzegorz T, et al.
Publicado: (2015)

Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas
por: Nili, Fatemeh, et al.
Publicado: (2020)

Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens
por: Sethi, Seema, et al.
Publicado: (2012)

Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Dong, Yanting, et al.
Publicado: (2020)

Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma
por: Wang, Feng, et al.
Publicado: (2021)

Human Tissue Distribution of TA02, Which is Homologous with a New Type of Aspartic Proteinase, Napsin A
por: Hirano, Takashi, et al.
Publicado: (2000)

Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses
por: Eo, Wan Kyu, et al.
Publicado: (2018)

High Diagnostic Accuracy of Epigenetic Imprinting Biomarkers in Thyroid Nodules
por: Xu, Huixiong, et al.
Publicado: (2023)

Diagnostic Accuracy of Contrast-Enhanced Ultrasound Enhancement Patterns for Thyroid Nodules
por: Zhang, Yan, et al.
Publicado: (2016)

The value of desmosomal plaque-related markers to distinguish squamous cell carcinoma and adenocarcinoma of the lung
por: Galindo, Inmaculada, et al.
Publicado: (2019)

The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D
por: Samukawa, Takuya, et al.
Publicado: (2012)

Immunocytochemical Evaluation of TTF-1, Napsin-A, and p-63 for Subtyping of Non-Small Cell Lung Carcinoma and Clinicopathological Correlation
por: Sharma, Tarun, et al.
Publicado: (2022)

The expression of podoplanin protein is a diagnostic marker to distinguish the early infiltration of esophageal squamous cell carcinoma
por: Chen, Guangyong, et al.
Publicado: (2017)

The diagnostic utility of inmunohistochemical and electronic microscopy in distinguishing between pleural mesothelioma and adenocarcinoma
por: Carrillo C, Carlos González, et al.
Publicado: (2007)

The Value of Sonography in Distinguishing Follicular Thyroid Carcinoma from Adenoma
por: Li, Wen, et al.
Publicado: (2021)

Diagnostic value of thyroid transcription factor-1 for pleural or other serous metastases of pulmonary adenocarcinoma: a meta-analysis
por: Shen, Yongchun, et al.
Publicado: (2016)

Lung adenocarcinoma and squamous cell carcinoma difficult for immunohistochemical diagnosis can be distinguished by lipid profile
por: Yamashita, Takashi, et al.
Publicado: (2023)

Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis
por: Huang, Tao, et al.
Publicado: (2016)

TGF-β1 induces CREB1-mediated miR-1290 upregulation to antagonize lung fibrosis via Napsin A
por: Guan, Shuhong, et al.
Publicado: (2020)

The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma – A Retrograde Single-Center Study from Croatia
por: Burazer, Marina Piljić, et al.
Publicado: (2017)

Accuracy of ultrasound in distinguishing pathology of malignant thyroid diseases: A protocol for systematic review and meta-analysis
por: Qin, Ling, et al.
Publicado: (2022)

Improving Diagnostic Accuracy for Distinguishing Buckle Fractures From Other Distal Radius Fractures in Children
por: Ruess, Lynne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cfj3fd95vqnsidmfc5s92cmkg2